 "Wockhardt declines ahead of Q4 results")
Shares of Wockhardt have dipped 9% to Rs 1,429 on the NSE in intra-day trades ahead of the January-March (Q4) quarter earnings today.
“The meeting of board of directors of the company will be held on May 28, 2015, to consider the annual audited consolidated and standalone financial statements of the company for the year ended March 31, 2015,” Wockhardt said in a statement.
For the nine months ended December 2014, the company had reported consolidated net profit of Rs 371 crore against Rs 766 crore in the same period last year.
Meanwhile, the drug maker said that US Food and Drug Administration (FDA) completed its inspection at its plants in Waluj and Chikalthana in Maharashtra.
"This is to inform you the exchange that inspection of our manufacturing unit at H14/2 Waluj, Aurangabad, Maharashtra by US FDA has since been completed,” the company said in a regulatory filing on clarification on news report.
In the past two weeks, the stock has appreciated by 24% compared to a 2.6% rise in the CNX Nifty till Wednesday.
At 1331 hours, the stock was down 7% at Rs 1,464 and a combined 3.55 million shares changed hands on the counter on the NSE and BSE.
“The meeting of board of directors of the company will be held on May 28, 2015, to consider the annual audited consolidated and standalone financial statements of the company for the year ended March 31, 2015,” Wockhardt said in a statement.
For the nine months ended December 2014, the company had reported consolidated net profit of Rs 371 crore against Rs 766 crore in the same period last year.
Meanwhile, the drug maker said that US Food and Drug Administration (FDA) completed its inspection at its plants in Waluj and Chikalthana in Maharashtra.
"This is to inform you the exchange that inspection of our manufacturing unit at H14/2 Waluj, Aurangabad, Maharashtra by US FDA has since been completed,” the company said in a regulatory filing on clarification on news report.
In the past two weeks, the stock has appreciated by 24% compared to a 2.6% rise in the CNX Nifty till Wednesday.
At 1331 hours, the stock was down 7% at Rs 1,464 and a combined 3.55 million shares changed hands on the counter on the NSE and BSE.